Maine Advances Psychedelic Research with Commission Bill Awaiting Governor’s Approval

LOS ANGELES- In a significant move towards exploring the therapeutic potential of psychedelic substances, Maine lawmakers have sent a bill to Governor Janet Mills that aims to establish a commission for studying and recommending regulatory frameworks for psychedelic services. The bill, known as LD 1914, has undergone amendments from its original version, shifting from legalizing psilocybin for therapeutic use to a more cautious approach focusing on research and future regulation.

The proposed commission, consisting of 13 members including legislative appointees, health experts, a military veteran, academics, and individuals with experience in psychedelics policy, is tasked with reviewing medical, psychological, and scientific studies on the safety and efficacy of psilocybin in treating behavioral health conditions. The commission is also expected to examine how other states have approached the regulation of psychedelics access and develop a long-term strategic plan for ensuring safe, accessible, and affordable psilocybin services for adults.

While the bill represents progress in the exploration of psychedelic therapies, it has been met with disappointment from advocates who hoped for more immediate access. Representative David Boyer (R), a vocal supporter of drug policy reform, acknowledged the legislation as a step forward, albeit not as substantial as desired.

The commission is authorized to meet six times and must deliver its report to the legislature by November 6, 2024. Governor Mills’ decision on the bill is anticipated, with the possibility of her signing it or allowing it to become law without her signature.

This development in Maine is part of a growing national trend, with several states considering or enacting measures related to psychedelic research and access. The move reflects a cautious yet progressive approach to exploring the potential therapeutic benefits of psychedelics while ensuring public safety and regulatory compliance.